Top
Topic: Primary and Secondary Brain Tumors

A special issue of Journal of Cancer Metastasis and Treatment

ISSN 2454-2857 (Online), ISSN 2394-4722 (Print)

Submission deadline: 30 Oct 2020

Guest Editor(s)

  • Dr. Lombardi Giuseppe, MD, PhD
    Department of Experimental and Clinical Oncology, Medical Oncology 1, Veneto Institute of Oncology-IRCCS, Padua, Italy

    Website | E-mail

  • Dr. Bellu Luisa, MD
    Radiotherapy Department, Radiotherapist at Veneto Institute of Oncology-IRCCS, Padua, Italy

    E-mail

  • Dr. Ius Tamara, MD
    Neurosurgery Unit, Department of Neurosciences, Santa Maria della Misericordia Univeristy Hospital, Udine, Italy

    E-mail

  • Dr. Villani Veronica, MD
    Neurology Department, Neurologists at Regina Elena Hospital, Rome, Italy

    E-mail

  • Dr. Caccese Mario, MD
    Oncology Department, Veneto Institute of Oncology-IRCCS, Padua, Italy

    E-mail

Special Issue Introduction

Primary tumors are a heterogenous group of neoplasms originating from brain. Since 2016 we have the new WHO classification incorporating new molecular characteristics, in particular IDH mutational status and 1p19q codeletion. Glioblastoma represents the most frequent primary brain tumor in adults and numerous studies were performed analyzing new treatments, such as regorafenib showing interesting results. Moreover, we have new approaches for radiotherapy and neurosurgery. New approaches for magnetic resonance imaging and positron emission tomography are integrated into diagnostic and follow up steps. Low grade gliomas and other primary and secondary brain tumors such as meningiomas or lung or melanoma metastases showed interesting responses to new treatment, in particular to combination of radiotherapy, immunotherapy and targeted therapy.This special issue will cover all aspects of primary and secondary brain tumors including current treatment options, radiation therapy, surgery, immunotherapy, imaging and molecular characteristics. Reviews will also be gratefully accepted.

Keywords

brain tumors, immunotherapy, brain metastases, glioblastoma

Submission Deadline

30 Oct 2020

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://jcmtjournal.com/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/jcmt
Submission Deadline: 30 Oct 2020
Contacts: Dina Li, managing editor, editorialoffice@jcmtjournal.com

Published Articles

This special issue is now open for submission.